Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2932)
All Articles published online
|
Sep 14, 2005 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu HC, Hung SK, Huang CJ, Chen CC, Chen MJ, Chang CC, Tai CJ, Tzen CY, Lu LH, Chen YJ. Esophagectomy for locally advanced esophageal cancer, followed by chemoradiotherapy and adjuvant chemotherapy. World J Gastroenterol 2005; 11(34): 5367-5372 [PMID: 16149148 DOI: 10.3748/wjg.v11.i34.5367] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i34/5367.htm |
| Number | Citing Articles |
| 1 |
Yun Luo, Xue-Fen Weng, Jia-Tao Huang, Xue-Hao Hu, Lai-Feng Wei, Yi-Wei Lin, Tian-Yan Ding, Biao Zhang, Ling-Yu Chu, Can-Tong Liu, Yu-Hui Peng, Yi-Wei Xu, Fang-Cai Wu. Nomogram constructed by immunological and inflammatory indicators for predicting prognosis of patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy plus surgery. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.882900
|
| 2 |
Alex G. Little, Antoon E. Lerut, David H. Harpole, Wayne L. Hofstetter, John D. Mitchell, Nasser K. Altorki, Mark J. Krasna. The Society of Thoracic Surgeons Practice Guidelines on the Role of Multimodality Treatment for Cancer of the Esophagus and Gastroesophageal Junction. The Annals of Thoracic Surgery 2014; 98(5): 1880 doi: 10.1016/j.athoracsur.2014.07.069
|
| 3 |
Su Pei, Jiang-Qiong Huang, Huan-Wei Liang, Yang Liu, Long Chen, Bin-Bin Yu, Wei Huang, Xin-Bin Pan. Adjuvant treatment patterns for pT3N0M0 esophageal cancer undergoing surgery. Diseases of the Esophagus 2024; 37(8) doi: 10.1093/dote/doae026
|
| 4 |
Bianca So, Loredana Marcu, Ian Olver, Raghu Gowda, Eva Bezak. Oesophageal cancer: Which treatment is the easiest to swallow? A review of combined modality treatments for resectable carcinomas. Critical Reviews in Oncology/Hematology 2017; 113: 135 doi: 10.1016/j.critrevonc.2017.03.004
|
| 5 |
Shufei Yu, Wencheng Zhang, Wenjie Ni, Zefen Xiao, Qifeng Wang, Zongmei Zhou, Qinfu Feng, Hongxing Zhang, Dongfu Chen, Jun Liang, Jima Lv, Zhouguang Hui, Jie He, Shugeng Gao, Kelin Sun, Dekang Fang, Xiangyang Liu, Yexiong Li. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy. Radiotherapy and Oncology 2019; 140: 159 doi: 10.1016/j.radonc.2019.06.020
|
| 6 |
Antonio Grandinetti. Treatment of Esophageal and Hypopharyngeal Squamous Cell Carcinoma. Updates in Surgery 2012; : 113 doi: 10.1007/978-88-470-2330-7_11
|
| 7 |
Yichun Wang, Fan Wang. <p>Postoperative Radiotherapy for Thoracic Esophageal Carcinoma with Upfront R0 Esophagectomy</p>. Cancer Management and Research 2020; : 13023 doi: 10.2147/CMAR.S286074
|
| 8 |
J. Zhang, Y. W. Zhang, Z. W. Chen, X. Y. Zhou, S. Lu, Q. Q. Luo, H. Hu, L. S. Miao, L. F. Ma, J. Q. Xiang. Adjuvant chemotherapy of cisplatin, 5-fluorouracil and leucovorin for complete resectable esophageal cancer: a case-matched cohort study in east China. Diseases of the Esophagus 2008; 21(3): 207 doi: 10.1111/j.1442-2050.2007.00748.x
|
| 9 |
Alicia Okines, Bhupinder Sharma, David Cunningham. Perioperative management of esophageal cancer. Nature Reviews Clinical Oncology 2010; 7(4): 231 doi: 10.1038/nrclinonc.2010.20
|
| 10 |
Shufei Yu, Wencheng Zhang, Wenjie Ni, Zefen Xiao, Xin Wang, Zongmei Zhou, Qinfu Feng, Dongfu Chen, Jun Liang, Dekang Fang, Yousheng Mao, Shugeng Gao, Yexiong Li, Jie He. Nomogram and recursive partitioning analysis to predict overall survival in patients with stage IIB-III thoracic esophageal squamous cell carcinoma after esophagectomy. Oncotarget 2016; 7(34): 55211 doi: 10.18632/oncotarget.10904
|
| 11 |
Junyi Li, Shaohua Ma. History and current situation of neoadjuvant treatment for locally advanced esophageal cancer. Thoracic Cancer 2021; 12(17): 2293 doi: 10.1111/1759-7714.14069
|
| 12 |
Hironori Tsujimoto, Satoshi Ono, Kentaro Chochi, Hidekazu Sugasawa, Takashi Ichikura, Hidetaka Mochizuki. Preoperative Chemoradiotherapy for Esophageal Cancer Enhances the Postoperative Systemic Inflammatory Response*. Japanese Journal of Clinical Oncology 2006; 36(10): 632 doi: 10.1093/jjco/hyl096
|
| 13 |
J Zhang, H-Q Chen, Y-W Zhang, J-Q Xiang. Adjuvant Chemotherapy in Oesophageal Cancer: A Meta-Analysis and Experience from the Shanghai Cancer Hospital. Journal of International Medical Research 2008; 36(5): 875 doi: 10.1177/147323000803600502
|
| 14 |
Scott MS Hurton, Jill A Hayden, Michele Molinari. Adjuvant therapy for resected pancreatic cancer. Cochrane Database of Systematic Reviews 2017; doi: 10.1002/14651858.CD011514.pub2
|
| 15 |
Fang Qiang, Ren Guangguo, Han Yongtao, Dong Dandan, Yang Hong. Multidrug Resistance in Primary Tumors and Metastases in Patients with Esophageal Squamous Cell Carcinoma. Pathology & Oncology Research 2013; 19(4): 641 doi: 10.1007/s12253-013-9623-3
|
| 16 |
Xiao Chang, Wei Deng, Wenjie Ni, Chen Li, Weiming Han, Lin-rui Gao, Shijia Wang, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Nan Bi, Shugeng Gao, Yu Lin, Junqiang Chen, Zefen Xiao. Comparison of Two Major Staging Systems in Predicting Survival and Recommendation of Postoperative Radiotherapy Based on the 11th Japanese Classification for Esophageal Carcinoma After Curative Resection: A Propensity Score-Matched Analysis. Annals of Surgical Oncology 2021; 28(12): 7076 doi: 10.1245/s10434-021-10046-6
|
| 17 |
Bingwen Zou, Yan Tu, Duwen Liao, Yong Xu, Jin Wang, Meijuan Huang, Li Ren, Jiang Zhu, Youling Gong, Yongmei Liu, Lin Zhou, Xiaojuan Zhou, Feng Peng, You Lu. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?. Thoracic Cancer 2020; 11(3): 631 doi: 10.1111/1759-7714.13307
|
| 18 |
Jin-Cheng Lu, Hua Tao, Zhen-Zhang Chen, Pu-Dong Qian. Prognostic factors of radiotherapy in patients with node-positive thoracic esophageal squamous cell carcinoma after radical surgery. Diseases of the Esophagus 2009; 22(6): 490 doi: 10.1111/j.1442-2050.2008.00936.x
|
| 19 |
Tao Song, Peng Chen, Min Fang, Xuebang Zhang, Dexi Du, Shixiu Wu. <p>The Role of Adjuvant Chemoradiotherapy Over Radiotherapy After R0 Resection for Stage II-III Esophageal Squamous Cell Carcinoma</p>. Cancer Management and Research 2020; : 1631 doi: 10.2147/CMAR.S232930
|
| 20 |
S. Gwynne, B.P.L. Wijnhoven, M. Hulshof, A. Bateman. Role of Chemoradiotherapy in Oesophageal Cancer — Adjuvant and Neoadjuvant Therapy. Clinical Oncology 2014; 26(9): 522 doi: 10.1016/j.clon.2014.05.015
|
| 21 |
Chih-Wen Chi, Chien-Chih Chen, Yu-Jen Chen. Therapeutic and Radiosensitizing Effects of Armillaridin on Human Esophageal Cancer Cells. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/459271
|
| 22 |
Bin Zheng, Wei Zheng, Yong Zhu, Xiao-yan Lin, Ben-hua Xu, Chun Chen. Role of adjuvant chemoradiotherapy in treatment of resectable esophageal carcinoma: a meta-analysis. Chinese Medical Journal 2013; 126(6): 1178 doi: 10.3760/cma.j.issn.0366-6999.20121798
|
| 23 |
Scott MS Hurton, Jill A Hayden, Michele Molinari, Michele Molinari. Cochrane Database of Systematic Reviews. 2015; doi: 10.1002/14651858.CD011514
|
| 24 |
Toni Lerut, Willy Coosemans, Georges Decker, Paul De Leyn, Johnny Moons, Philippe Nafteux, Dirk Van Raemdonck. Diagnosis and therapy in advanced cancer of the esophagus and the gastroesophageal junction. Current Opinion in Gastroenterology 2006; 22(4): 437 doi: 10.1097/01.mog.0000231822.48890.3d
|
| 25 |
Yu-Zhen Zheng, Wei Zhao, Yi Hu, Xiao-Xiao Ding-Lin, Jing Wen, Hong Yang, Qian-Wen Liu, Kong-Jia Luo, Qing-Yuan Huang, Jun-Ying Chen, Jian-Hua Fu. Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status. World Journal of Gastroenterology 2015; 21(28): 8644-8652 doi: 10.3748/wjg.v21.i28.8644
|
| 26 |
Qing Guo, Jia He, Feng Shen, Wei Zhang, Xi Yang, Chi Zhang, Qu Zhang, Jun-Xing Huang, Zheng-Dong Wu, Xin-Chen Sun, Sheng-Bin Dai. TCN, an AKT inhibitor, exhibits potent antitumor activity and enhances radiosensitivity in hypoxic esophageal squamous cell carcinoma in vitro and in vivo. Oncology Letters 2017; 13(2): 949 doi: 10.3892/ol.2016.5515
|
| 27 |
Vahide I. Ugur, Sakire P. Kara, Bulent Kucukplakci, Taciser Demirkasimoglu, Cem Misirlioglu, Aytul Ozgen, Yesim Elgin, Ergun Sanri, Kadri Altundag, Nadi Ozdamar. Clinical characteristics and outcome of patients with stage III esophageal carcinoma: a single-center experience from Turkey. Medical Oncology 2008; 25(1): 63 doi: 10.1007/s12032-007-0043-7
|